Karyopharm Therapeutics Inc. · NASDAQ:KPTI

The Vanguard Group reported a 4.70% stake in Karyopharm Therapeutics Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Oct 30, 2025

The Vanguard Group reported a 4.70% stake in Karyopharm Therapeutics Inc., 408,222 shares, as a passive investor on Sep 30, 2025. Filed Oct 30, 2025 (Schedule 13G/A).

Stake
4.70%
Shares
408,222
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
The Vanguard Group4.70%408,222

Source

View original at SEC

Related